Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

Author： Argyris E.   Paterson Y.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.2, 1998-12, pp. : 239-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite

Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 62-72

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1- Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview

By  

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1874-1898

Bentham Science Publishers

Access to resources Recommend Favorite

Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

By  

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3335-3342

Bentham Science Publishers

Access to resources Recommend Favorite